Catalyst Capital Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-85
Closed -$7K 435
2019
Q3
$7K Buy
85
+33
+63% +$2.72K ﹤0.01% 376
2019
Q2
$5K Buy
+52
New +$5K ﹤0.01% 396